EX-99.1 2 u92608exv99w1.htm EX-99.1 SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET AS OF DEC. 31, 2004 AND SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS AND CASH FLOWS FOR THE YEAR ENDED DEC. 31, 2004 SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET
 

Exhibit 99.1
STATS CHIPPAC LTD. AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET
As of December 31, 2004
In thousands of U.S. Dollars
                                                             
            STATS                
    STATS       ChipPAC   Guarantor   Non-Guarantor        
    ChipPAC   ChipPAC   Korea   Subsidiaries   Subsidiaries   Eliminations   Consolidated
                             
ASSETS
Current assets:
                                                       
 
Cash and cash equivalents
  $ 184,824     $ 533     $ 1,976     $ 19,002     $ 21,174     $     $ 227,509  
 
Marketable securities
                      787       1,273             2,060  
 
Accounts receivable, net
    66,875                   70,444       12,331             149,650  
 
Amounts due from affiliates
    250,479       194,605       13,002       66,326       3,719       (525,508 )     2,623  
 
Other receivables
    8,022       70       7,620       863       238             16,813  
 
Inventories
    19,916             23,868       4,572       6,334             54,690  
 
Prepaid expenses and other assets
    32,971       1,525       273       740       3,327             38,836  
                                           
   
Total current assets
    563,087       196,733       46,739       162,734       48,396       (525,508 )     492,181  
Marketable securities
    18,097                         24             18,121  
Prepaid expenses
    7,072             5,224                         12,296  
Property, plant and equipment, net
    391,523       4,912       199,234       176,780       263,530       (176 )     1,035,803  
Investment in subsidiaries
    750,620                               (750,620 )      
Intangible assets
    1,398       2,802       1,816       118,358       1,456             125,830  
Goodwill
                312,758       102,591       106,040       2,209       523,598  
Other assets
    34,614       487       23,018       184       5,570             63,873  
                                           
   
Total assets
  $ 1,766,411     $ 204,934     $ 588,789     $ 560,647     $ 425,016     $ (1,274,095 )   $ 2,271,702  
                                           
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
                                                       
 
Accounts payable
  $ 7,957     $ 2,314     $ 41,448     $ 2,148     $ 14,714     $ (8 )   $ 68,573  
 
Payables related to property, plant and equipment purchases
    20,028       4       9,610       8,268       13,728             51,638  
 
Accrued operating expenses
    36,773       8,307       4,382       6,953       7,484             63,899  
 
Income taxes payable
          13       1,555       450       20             2,038  
 
Short-term borrowings
                19,874                         19,874  
 
Amounts due to affiliates
    4,941       173       50,205       437,110       33,216       (525,508 )     137  
 
Current obligations under capital leases
    805             6,782                         7,587  
 
Current installments of long-term debt
    137,107                         17,300             154,407  
                                           
   
Total current liabilities
    207,611       10,811       133,856       454,929       86,462       (525,516 )     368,153  
Obligations under capital leases, excluding current installments
                10,771                         10,771  
Long-term debt, excluding current installments
    399,182       200,000                   42,993             642,175  
Other non-current liabilities
    268             35,792       10,189       4,113             50,362  
                                           
   
Total liabilities
    607,061       210,811       180,419       465,118       133,568       (525,516 )     1,071,461  
                                           
Minority interest
                                  40,891       40,891  
Issued shares
    298,233       991                   81,535       (82,526 )     298,233  
Additional paid-in capital
    1,507,854       291,795       614,115       429,405       353,997       (1,689,554 )     1,507,612  
Accumulated other comprehensive loss
    (2,860 )     (5,993 )     12,492             4,417       (10,916 )     (2,860 )
Accumulated earnings (deficit)
    (643,877 )     (292,670 )     (218,237 )     (333,876 )     (148,501 )     993,526       (643,635 )
                                           
   
Total shareholders’ equity
    1,159,350       (5,877 )     408,370       95,529       291,448       (789,470 )     1,159,350  
                                           
   
Total liabilities and shareholder’s equity
  $ 1,766,411     $ 204,934     $ 588,789     $ 560,647     $ 425,016     $ (1,274,095 )   $ 2,271,702  
                                           

 


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the Year Ended December 31, 2004
In thousands of U.S. Dollars
                                                             
            STATS                
    STATS       ChipPAC   Guarantor   Non-Guarantor        
    ChipPAC   ChipPAC   Korea   Subsidiaries   Subsidiaries   Eliminations   Consolidated
                             
Net revenues
  $ 462,697     $ 9,703     $ 148,382     $ 259,785     $ 83,382     $ (194,828 )   $ 769,121  
Cost of revenues
    (390,673 )     (203 )     (130,630 )     (243,295 )     (73,690 )     194,951       (643,540 )
                                           
Gross profit (loss)
    72,024       9,500       17,752       16,490       9,692       123       125,581  
                                           
Operating expenses:
                                                       
 
Selling, general and administrative
    42,877       7,682       3,271       25,862       5,273             84,965  
 
Research and development
    10,811       1,047       2,933       1,952       894             17,637  
 
Goodwill impairment
                271,734       89,135       92,131             453,000  
 
Other general expenses (income), net
    (618 )     121             33       (44 )     44       (464 )
                                           
   
Total operating expenses
    53,070       8,850       277,938       116,982       98,254       44       555,138  
                                           
Operating income (loss)
    18,954       650       (260,186 )     (100,492 )     (88,562 )     79       (429,557 )
                                           
Other income (expense), net:
                                                       
 
Interest income
    7,774       9       59       3,596       123       (7,131 )     4,430  
 
Interest expense
    (19,173 )     (2,875 )     (1,399 )     (10,944 )     (1,556 )     7,131       (28,816 )
 
Foreign currency exchange gain (loss)
    (206 )           (1,915 )     881       118             (1,122 )
 
Equity income (loss) from investment in subsidiaries
    (472,535 )     (67,882 )           (87,677 )           628,094        
Other non-operating income, net
    (675 )     12       11       (542 )     258             (936 )
                                           
Total other income (expense), net
    (484,815 )     (70,736 )     (3,244 )     (94,686 )     (1,057 )     628,094       (26,444 )
                                           
Income (loss) before income taxes
    (465,861 )     (70,086 )     (263,430 )     (195,178 )     (89,619 )     628,173       (456,001 )
Income tax benefit (expense)
    (1,862 )     (14 )     (6,500 )     (515 )     997             (7,894 )
                                           
Loss before minority interest
    (467,723 )     (70,100 )     (269,930 )     (195,693 )     (88,622 )     628,173       (463,895 )
Minority interest
                                  (3,828 )     (3,828 )
                                           
Net income (loss)
  $ (467,723 )   $ (70,100 )   $ (269,930 )   $ (195,693 )   $ (88,622 )   $ 624,345     $ (467,723 )
                                           

 


 

STATS CHIPPAC LTD. AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Year Ended December 31, 2004
In thousands of U.S. Dollars
                                                         
            STATS       Non-        
    STATS       ChipPAC   Guarantor   Guarantor        
    ChipPAC   ChipPAC   Korea   Subsidiaries   Subsidiaries   Eliminations   Consolidated
                             
Cash Flows From Operating Activities
                                                       
Net income (loss)
  $ (467,723 )   $ (70,100 )   $ (269,930 )   $ (195,693 )   $ (88,622 )   $ 624,345     $ (467,723 )
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
                                                       
Depreciation and amortization
    104,141       628       17,008       37,312       29,638       (44 )     188,683  
Goodwill impairment
                271,734       89,135       92,131             453,000  
Amortization of leasing prepayments
    25,718                                     25,718  
Debt issuance cost amortization
    1,741                         172             1,913  
Loss (gain) on sale of property, plant and equipment
    (631 )                 5       (30 )           (656 )
Accretion of discount on convertible notes
    11,923                   (486 )                 11,437  
Loss from early debt extinguishment
    266                   531                   797  
Foreign currency exchange loss (gain)
    (516 )                       (314 )           (830 )
Deferred income taxes
    9,145             6,204       461       (805 )           15,005  
Minority interest in income (loss) of subsidiary
                                  3,828       3,828  
Equity loss from investment in subsidiaries
    472,535       67,882             87,677             (628,094 )      
(Gain) loss on sale and maturity of marketable securities
    503                         34             537  
Others
    1,162       127             (193 )     (32 )     (35 )     1,029  
Changes in operating working capital:
                                                       
Accounts receivable
    3,670                   8,789       (4,310 )           8,149  
Amounts due from affiliates
    (242,237 )     26,486       (1,171 )     6,976       15,986       198,387       4,427  
Inventories
    (77 )           (632 )     (314 )     (148 )           (1,171 )
Other receivables, prepaid expenses and other assets
    (64,078 )     (1,442 )     (2,459 )     2,683       875             (64,421 )
Accounts payable, accrued operating expenses and other payables
    (2,709 )     (23,934 )     3,506       (14,644 )     (3,625 )           (41,406 )
Amounts due to affiliates
    (2,918 )     (85 )     94       191,182       8,415       (198,387 )     (1,699 )
                                           
Net cash provided by operating activities
  $ (150,085 )   $ (438 )   $ 24,354     $ 213,421     $ 49,365     $     $ 136,617  
                                           
Cash Flows From Investing Activities
                                                       
Proceeds from sales of marketable securities
  $ 101,323     $     $     $     $ 29,174     $     $ 130,497  
Proceeds from maturity of marketable securities
    46,687                                     46,687  
Purchases of marketable securities
    (137,124 )                 222       (24,041 )           (160,943 )
Acquisition of intangible assets
          (399 )     (45 )     (510 )     (474 )           (1,428 )
Acquisition of subsidiary, net of cash acquired
    (14,049 )                       4,680       16,577       7,208  
Purchases of property, plant and equipment
    (172,320 )     (1,090 )     (35,893 )     (24,434 )     (81,225 )     27,388       (287,574 )
Others, net
    20,926       33       133       3,011       4,014       (27,388 )     729  
                                           
Net cash used in investing activities
  $ (154,557 )   $ (1,456 )   $ (35,805 )   $ (21,711 )   $ (67,872 )   $ 16,577     $ (264,824 )
                                           
Cash Flows From Financing Activities
                                                       
Repayment of short-term debt
  $ (50,000 )   $     $     $     $ (22,006 )   $     $ (72,006 )
Repayment of long-term debt
                            (8,982 )           (8,982 )
Proceeds from issuance of shares, net of expenses
    1,968                                     1,968  
Proceeds from issuance of convertible and senior notes, net of expenses
    210,458                                     210,458  
Repurchase of senior and convertible notes
    (18,083 )                 (175,564 )                 (193,647 )
Proceeds from bank borrowings
    50,000             8,016             49,604             107,620  
Decrease in restricted cash
                            2,927             2,927  
Capital lease payments
    (2,042 )           (1,727 )     (2,663 )     (778 )           (7,210 )
                                           
Net cash provided by (used in) financing activities
  $ 192,301     $     $ 6,289     $ (178,227 )   $ 20,765     $     $ 41,128  
                                           
Net decrease in cash and cash equivalents
  $ (112,341 )   $ (1,894 )   $ (5,162 )   $ 13,483     $ 2,258     $ 16,577     $ (87,079 )
Effect of exchange rate changes on cash and cash equivalents
                            1,425             1,425  
Cash and cash equivalents at beginning of the year/period
    297,165       2,427       7,138       5,519       17,491       (16,577 )     313,163  
                                           
Cash and cash equivalents at end of the year
  $ 184,824     $ 533     $ 1,976     $ 19,002     $ 21,174     $     $ 227,509